Ligand-specific regulation of a binary enhancer code dictating cellular senescence
Abstract
Cellular senescence, a major contributor to aging and age-related pathologies, is characterized by irreversible proliferative arrest and a disease-linked, proinflammatory profile known as the Senescence Associated Secretory Phenotype (SASP). A critical unanswered question is whether these properties are regulated by specific enhancer subsets, potentially licensing strategies that selectively block deleterious SASP components. Here, we identify two functionally distinct and independently regulated enhancer programs underlying senescence that are controlled by different TGF-β family ligands. Whereas Activin A stimulates recruitment of nuclear factor IA/C (NFIA/C) and SMAD2/3 transcription factors to an enhancer network that induces proliferation arrest, TGF-β2 promotes SMAD2/3-mediated suppression of a p65-dependent enhancer cohort driving the SASP. We have also uncovered reciprocal SMAD2/3-super-enhancer-regulated feedback loops that govern expression of the TGF-β2 ( TGFB2) and Activin A ( INHBA ) transcription units, both of which are significantly up-regulated in replicative senescence. The characteristic enhancer usage and transcriptional landscape of high-passage senescent cells are sensitive to rapamycin treatment, discontinuation of which results in robust but selective senescent enhancer activation and exacerbation of the SASP. Collectively, this study uncovers separable enhancer programs and their key constituent transcription factors that contribute to the canonical features of cellular senescence, potentially informing the development of SASP-targeted therapies.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (8)
Thomas Suter
Cellular and Molecular Medicine, Department of Medicine, University of California San Diego
Meyer J. Friedman
Cellular and Molecular Medicine, Department of Medicine, University of California San Diego
Cagdas Tazearslan
Department of Genetics, Albert Einstein College of Medicine
Daria Merkurjev
Cellular and Molecular Medicine, Department of Medicine, University of California San Diego
Kenny Ohgi
Cellular and Molecular Medicine, Department of Medicine, University of California San Diego
Dario Meluzzi
Cellular and Molecular Medicine, Department of Medicine, University of California San Diego
Michael G. Rosenfeld
Cellular and Molecular Medicine, Department of Medicine, University of California San Diego
Yousin Suh